Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

NCT06908096 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

750

Enrollment

NIH

Sponsor class

Conditions

EBV
Epstein-Barr Virus Infection
Infectious Mononucleosis
Mono

Interventions

BIOLOGICAL: EBV gp350-ferritin vaccine with ALFQ adjuvant
BIOLOGICAL: EBV gH/gL/gp42-ferritin nanoparticle vaccine with ALFQ adjuvant

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)